Abstract
All-trans retinoic acid (ATRA), a derivative of vitamin A, is the first line drug for acute promyelocytic leukemia (APL). At the same time, ATRA is also associated with various side effects, including some life threatening conditions. We describe a case of ATRA-induced pseudotumor cerebri in an adult patient of APL.
Key words: All-trans retinoic acid, Pseudotumor cerebri, Adult, Acute promyelocytic leukemia